Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALIUS LIMITED Director's Dealing 2023

Mar 9, 2023

65058_rns_2023-03-09_f207aff4-a778-46f5-9ba5-06cba14a2729.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity HEALIUS LIMITED
ABN 24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Gordon Richard Davis
Date of last notice 11 November 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving
rise to the relevant interest.
As shown
Date of change 10 March 2023
No. of securities held prior to
change
16,064 Ordinary Shares
Gordon Davis
55,759 Ordinary Shares
GR & G Davis
Superannuation Fund
24,150 NED Share Rights Gordon Davis
_

_Shares are subject to a holding lock as “Restricted

Securities” under the NED Share Plan.
Class Fully paid Ordinary Shares
Number acquired 12,075
Number disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details
and estimated valuation
$40,000 cash equivalent using the volume weighted
average price of Ordinary Shares over the five business
days immediately following the Healius Limited Annual
General Meeting on 20 October 2022, being $3.3126.
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

28,139 Ordinary Shares Gordon Davis GR & G Davis 55,759 Ordinary Shares No. of securities held after Superannuation Fund change 12,075 NED Share Rights Gordon Davis _ Shares are subject to a holding lock as “Restricted Shares” under the NED Share Plan._ Nature of change Vesting of 50% of NED Share Rights issued in respect Example: on-market trade, off-market trade, exercise of options, issue of securities under of FY 2023 into Ordinary Shares (restricted) under the dividend reinvestment plan, participation in buyNED Share Plan. back

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts
detailed above traded during a+closed period where
prior written clearance was required?
N/A
If so, was prior written clearance provided to allow the
trade to proceed during this period?
N/A
If prior written clearance was provided, on what date
was this provided?
N/A

Authorised by the Company Secretary.

Charles Tilley Company Secretary Date: 10 March 2023

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011